Newsfeeds - Spark Newswire

1 minute read

BiondVax Pharmaceuticals Q2 EPS $(0.10) Down From $(0.03) YoY

Today, 3:51 PM

BiondVax Pharmaceuticals (NASDAQ:BVXV) reported quarterly losses of $(0.10) per share. This is a 233.33 percent decrease over losses of $(0.03) per share from the same period last year.

BVXV

3 minute read

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck

By Shanthi Rexaline

Today, 3:51 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18)

ABBV

10 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 3:51 PM

Wednesday morning, 136 companies reached new 52-week lows.

ADMA

6 minute read

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios’ Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

By Shanthi Rexaline

Today, 3:51 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17)

ABBV

20 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 3:51 PM

Tuesday morning, 282 companies set new 52-week lows.

AAOI

8 minute read

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

By Shanthi Rexaline

Today, 3:51 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16)

ABSI

14 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 3:51 PM

On Monday morning, 207 companies hit new 52-week lows.

ACAD

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 3:51 PM

Gainers

ACOR

4 minute read

The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay

By Shanthi Rexaline

Today, 3:51 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20)

ABCL

5 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 3:51 PM

Before 10 a.m. ET Tuesday, 64 stocks made new 52-week lows.

ABCL